1.Brammer LM, Abrego PJ, Shostrom EL. Therapeuticcounseling and psychotherapy: Prentice-Hall, Inc;1992.Oey O, SunjayaAPApplicationsofnanoparticlesincardiovascularimagingandtherapeuticsAsianCardiovascThoracAnn2022:021843.Tarride J-E, Lim M, DesMeules M, Luo W, Burke N,O’Reilly D, et al. A review of the cost ofcardiovascular disease. Can J Cardiol 2009;25(6):195-2024.Thompson JB, Blaha M, Resar JR, Blumenthal RS,Desai MY. Strategies to reverse atherosclerosis: an
imaging perspective. Curr Treat Options CardiovascMed. 2008;10(4):283-93.5.Ueshima H, Sekikawa A, Miura K, Turin TC,
Takashima N, Kita Y, et al. Cardiovascular diseaseand risk factors in Asia: a selected review.Circulation.2008;118(25):2702-9.
6.Wang X, Kaiser H, Kvist-Hansen A, McCauley BD,Skov L, Hansen PR, et al. IL-17 Pathway Members asPotentialBiomarkers of Effective Systemic Treatmentand Cardiovascular Disease in Patients withModerate-to-Severe Psoriasis. Int J Mol Sci.
2022;23(1):555.7.Griffiths CE, ArmstrongAW,GudjonssonJE,BarkerJN.Psoriasis.TheLance2021;397(10281):1301-15.8.Iwakura Y, Ishigame H, Saijo S, Nakae S. Functionalspecialization of interleukin-17 family members.Immunity. 2011;34(2):149-62.
9.Karbach S, Croxford AL, Oelze M, Schüler R,Minwegen D, Wegner J, et al. Interleukin 17 drivesvascular inflammation, endothelial dysfunction, andarterial hypertension in psoriasis-like skindisease. Arterioscler Thromb Vasc Biol2014;34(12):2658-68.10.Kurschus FC, Moos S. IL-17 for therapy. Journal ofDermatological Science. 2017;87(3):221-7.
11.Sanda G, Belur A, Teague H, Mehta NN. Emergingassociations between neutrophils, atherosclerosis, andpsoriasis. Curr Atheroscler Rep 2017;19(12):1-8.12.Rosales C, Uribe-Querol E. Phagocytosis: afundamental process in immunity. Biomed Res Int2017;2017.13.Rabinovitch M. Professional and non-professionalphagocytes: an introduction. Trends Cell Biol
1995;5(3):85-7.14.Flannagan RS, Jaumouillé V, Grinstein S. The cellbiology of phagocytosis. Annu Rev Pathol 2012;7:61-98.
15.Gordon S. Phagocytosis :An ImmunobiologicProcess. Immunity. 2016;44(3):463-75.16.Freeman SA, Grinstein S.Phagocytosis: receptors,signal integration, and the cytoskeleton. ImmunolRevi 2014;262(1):193-215.17.Campbell-Valois F-X, Trost M, Chemali M, Dill BD,Laplante A, Duclos S, et al. Quantitative proteomicsreveals that only a subset of the endoplasmic reticulumcontributes to the phagosome. Mol Cell Proteomics2012;11(7):M111. 016378-1-M111. -13.
18.Nair-Gupta P, Baccarini A, Tung N, Seyffer F,Florey O, Huang Y, et al. TLR signals inducephagosomal MHC-I deliveryfrom the endosomalrecycling compartment to allow cross-presentation.Cell. 2014;158(3):506-21.19.Joffre OP, Segura E, Savina A, Amigorena S. Cross-presentation by dendritic cell Nat Rev Immunol2012;12(8):557-69.20.Carbone F, Nencioni A, Mach F, Vuilleumier N,Montecucco F. Pathophysiological role of neutrophilsin acute myocardial infarction. Thromb Haemost2013;110(09):501-1421.Döring Y, Drechsler M ,Soehnlein O, Weber CNeutrophils in atherosclerosis: from mice to man.Arterioscler Thromb Vasc Biol 2015;35(2):288-95.22.Grant W, Jeffrey E, Christopher P. Acute myocardial
infarction. Lancet. 2017;389(10065):197-210.23.Xu J-Y, Xiong Y-Y, Lu X-T, Yang Y-J. Regulationof type2immunityinmyocardial infarction.Front immunol 2019;10:62.24.Zhao E, Xie H, Zhang Y. Predicting diagnostic genebiomarkers associated with immune infiltration inpatients with acute myocardial infarction.Front Cardiovasc Med 2020:201.25.Iyer RP, Jung M, Lindsey ML. MMP-9 signaling inthe left ventricle following myocardial infarction.Am J. Physiol Heart Circ 2016;311(1):H190-H8.26.Gay NJ, Symmons MF, Gangloff M, Bryant CE.Assembly and localization of Toll-ikereceptorsignalling complexes. Nat Rev Immunol2014;14(8):546-58.27.Yang Y, Lv J, Jiang S, Ma Z, Wang D, Hu W, et al.The emerging role of Toll-like receptor 4 inmyocardial inflammation. Cell Death Dis2016;7(5):e2234-e.28.Dehn S, Thorp EB. Myeloid receptor CD36 isrequired for early phagocytosis of myocardial infarctsand induction of Nr4a1‐dependent mechanisms ofcardiac repair. The FASEB Journal 2018;32(1):254-64